Literature DB >> 25942648

Gap analysis of pharmacokinetics and pharmacodynamics in burn patients: a review.

Amanda N Steele1, Kristin N Grimsrud, Soman Sen, Tina L Palmieri, David G Greenhalgh, Nam K Tran.   

Abstract

Severe burn injury results in a multifaceted physiological response that significantly alters drug pharmacokinetics and pharmacodynamics (PK/PD). This response includes hypovolemia, increased vascular permeability, increased interstitial hydrostatic pressure, vasodilation, and hypermetabolism. These physiologic alterations impact drug distribution and excretion-thus varying the drug therapeutic effect on the body or microorganism. To this end, in order to optimize critical care for the burn population it is essential to understand how burn injury alters PK/PD parameters. The purpose of this article is to describe the relationship between burn injury and drug PK/PD. We conducted a literature review via PubMed and Google to identify burn-related PK/PD studies. Search parameters included "pharmacokinetics," "pharmacodynamics," and "burns." Based on our search parameters, we located 38 articles that studied PK/PD parameters specifically in burns. Twenty-seven articles investigated PK/PD of antibiotics, 10 assessed analgesics and sedatives, and one article researched an antacid. Out of the 37 articles, there were 19 different software programs used and eight different control groups. The mechanisms behind alterations in PK/PD in burns remain poorly understood. Dosing techniques must be adapted based on burn injury-related changes in PK/PD parameters in order to ensure drug efficacy. Although several PK/PD studies have been undertaken in the burn population, there is wide variation in the analytical techniques, software, and study sample sizes used. In order to refine dosing techniques in burns and consequently improve patient outcomes, there must be harmonization among PK/PD analyses.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25942648     DOI: 10.1097/BCR.0000000000000120

Source DB:  PubMed          Journal:  J Burn Care Res        ISSN: 1559-047X            Impact factor:   1.845


  5 in total

1.  Pharmacogenetic Gene-Drug Associations in Pediatric Burn and Surgery Patients.

Authors:  Kristin N Grimsrud; Ryan R Davis; Clifford G Tepper; Tina L Palmieri
Journal:  J Burn Care Res       Date:  2022-09-01       Impact factor: 1.819

2.  Identification of Cytochrome P450 Polymorphisms in Burn Patients and Impact on Fentanyl Pharmacokinetics: A Pilot Study.

Authors:  Kristin N Grimsrud; Xenia Ivanova; Catherine M Sherwin; Tina L Palmieri; Nam K Tran
Journal:  J Burn Care Res       Date:  2019-01-01       Impact factor: 1.845

Review 3.  Antibiotic Prophylaxis in Torso, Maxillofacial, and Skin Traumatic Lesions: A Systematic Review of Recent Evidence.

Authors:  Enrico Cicuttin; Massimo Sartelli; Emanuele Scozzafava; Dario Tartaglia; Camilla Cremonini; Bruno Brevi; Niccolò Ramacciotti; Serena Musetti; Silvia Strambi; Mauro Podda; Fausto Catena; Massimo Chiarugi; Federico Coccolini
Journal:  Antibiotics (Basel)       Date:  2022-01-21

4.  Meropenem pharmacokinetics in critically ill patients with or without burn treated with or without continuous veno-venous haemofiltration.

Authors:  Daniel J Selig; Kevin S Akers; Kevin K Chung; Kaitlin A Pruskowski; Jeffrey R Livezey; Elaine D Por
Journal:  Br J Clin Pharmacol       Date:  2021-12-09       Impact factor: 3.716

5.  Population Pharmacokinetic Modeling and Simulations of Imipenem in Burn Patients With and Without Continuous Venovenous Hemofiltration in the Military Health System.

Authors:  Elaine D Por; Kevin S Akers; Kevin K Chung; Jeffrey R Livezey; Daniel J Selig
Journal:  J Clin Pharmacol       Date:  2021-06-19       Impact factor: 3.126

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.